Why is Astec Lifescienc falling/rising?

As of 23-Sep, Astec Lifesciences Ltd is experiencing a decline in its stock price, currently at Rs 829.05, which reflects a decrease of Rs 16.95 or 2.0%. Today's price summary indicates that the stock underperformed its sector by 0.8%, with an intraday high of Rs 864 and a low of Rs 829.05. The stock has shown significant underperformance over various time frames, with a 1-month return of -9.19% and a year-to-date return of -17.51%. The company's financial health is concerning, as it has reported operating losses for the last five consecutive quarters, a high Debt to EBITDA ratio of 2.64, and a negative EBITDA, indicating a weak long-term fundamental strength and low profitability.
Broader market context shows that while the Sensex has gained 0.98% over the past month, Astec Lifesciences has continued to struggle, reflecting a consistent underperformance against the benchmark. The stock's performance over the last three years has been particularly poor, with a return of -55.98% compared to a 41.31% gain in the benchmark. This stark contrast highlights the challenges faced by the company, including declining profits and rising interest expenses, which contribute to the negative sentiment surrounding the stock and its current price decline.